Abstract
A 22-year-old man, in first complete remission of acute myelogenous leukemia, developed a high grade B cell lymphoma 19 months after an allogeneic bone marrow transplant (allo-BMT) from an HLA-identical unrelated donor. Biopsy of a cervical lymph node revealed a lymphoma that was negative for Epstein–Barr virus-encoded small nuclear RNAs (EBERs) in situhybridization. Genotypic analyses identified the lymphoma to be of donor origin, and there was no evidence of the Epstein–Barr virus (EBV) DNA in the lymphoma by Southern blot analysis. The lymphoma went into complete remission, following four courses of combination chemotherapy, but relapsed after a month and the patient died of congestive heart failure. The patient was thought to be persistently immunosuppressed 11 months after cessation of immunosuppressants, and the lymphoma was thought to be induced by one or more factors other than EBV. Bone Marrow Transplantation (2000) 26, 577–579.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bhatia S, Ramsay NKC, Steinbuch M et al. Malignant neoplasms following bone marrow transplantation Blood 1996 87: 3633–3639
Lones MA, Lopez-Terrada D, Shintaku IP et al. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization Arch Pathol Lab Med 1998 122: 708–714
Zutter MM, Martin PJ, Sale GE et al. Epstein–Barr virus lymphoproliferation after bone marrow transplantation Blood 1988 72: 520–529
Shapiro RS, McClain K, Frizzera G et al. Epstein–Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation Blood 1988 71: 1234–1243
Knowles DM, Cesarman E, Chadburn A et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders Blood 1995 85: 552–565
Verschuur A, Brousse N, Raynal B et al. Donor B cell lymphoma of the brain after allogeneic bone marrow transplantation for acute myeloid leukemia Bone Marrow Transplant 1994 14: 467–470
Schouten HC, Hopman AHN, Haesevoets AM, Arends J-W . Large-cell anaplastic non-Hodgkin's lymphoma originating in donor cells after allogeneic bone marrow transplantation Br J Haematol 1995 91: 162–166
Trimble MS, Waye JS, Walker IR et al. B-cell lymphoma of recipient origin 9 years after allogeneic bone marrow transplantation for T-cell acute lymphoblastic leukaemia Br J Haematol 1993 85: 99–102
Meignin V, Devergie A, Brice P et al. Hodgkin's disease of donor origin after allogeneic bone marrow transplantation for myelogeneous chronic leukemia Transplantation 1998 65: 595–597
O'Riordan JM, Molloy K, O'Briain DS et al. Localized, late-onset, high-grade lymphoma following bone marrow transplantation: response to combination chemotherapy Br J Haematol 1994 86: 183–186
Magrath I, Adde M, Shad A et al. Adult and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen J Clin Oncol 1996 14: 925–934
Acknowledgements
We thank Dr Seiya Hirohata (Department of Gastroenterology, Hyogo Medical Center for Adults) for ultrasonographic diagnosis, Dr Hiroshi Ueno (Department of Medicine, Hyogo Medical Center for Adults) for cardiac diagnosis and the nursing and laboratory staffs of Hyogo Medical Center for Adults. We also thank SRL for in situ hybridization and DNA analysis.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gomyo, H., Murayama, T., Kizaki, T. et al. Epstein–Barr virus-negative high grade B cell lymphoma of donor origin developing 19 months after unrelated allogeneic bone marrow transplantation. Bone Marrow Transplant 26, 577–579 (2000). https://doi.org/10.1038/sj.bmt.1702548
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702548